Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Oncotarget|July 28, 2015
Human saliva as route of inter-human infection for mouse mammary tumor virusChiara Maria Mazzanti, Francesca Lessi, Ivana Armogida, et al.Journal of Medical Genetics|January 6, 2016
Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesiaMichele Lai, Massimo Pifferi, Andrew Bush, et al.Journal of the American Heart Association|March 10, 2026
Continuous Versus Intermittent Loop Diuretics Step-by-Step Protocol in Acute Heart Failure (DIUR-AHF): A Propensity-Matched AnalysisGaetano Ruocco, Andrea Salzano, Sara Franceschi, et al.Oncotarget|May 31, 2018
Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer playersSara Franceschi, Francesca Lessi, Paolo Aretini, et al.Investigational New Drugs|October 2, 2017
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapyFrancesco Pasqualetti, Alessandra Gonnelli, Martina Cantarella, et al.Scientific Reports|August 9, 2018
Serotonin depletion causes valproate-responsive manic-like condition and increased hippocampal neuroplasticity that are reversed by stressGiacomo Maddaloni, Sara Migliarini, Francesco Napolitano, et al.Investigational New Drugs|February 9, 2021
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapyFrancesco Pasqualetti, Alessandra Gonnelli, Paola Orlandi, et al.Neuro-Oncology Advances|June 29, 2026
Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastomaMariangela Morelli, Francesca Di Lorenzo, Francesca Marchetto, et al.Cell Death Discovery|April 13, 2026
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerabilitySara Franceschi, Mariangela Morelli, Francesca Lessi, et al.Frontiers in Oncology|July 13, 2019
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast CancerMarco La Ferla, Francesca Lessi, Paolo Aretini, et al.Pageof 5